Investor Relations

Latest News

Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filing Details

Document Details

Form
8-K
Filing Date
Sep 14, 2018
Document Date
Sep 14, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
OPKO Health, Inc.